THYROCARE — Thyrocare Technologies Limited

NSE · AI Signal & Stock Analysis · Neutral

As of Aug 14 2026, 6:50 PM, AkshayaAI's signal for THYROCARE is Neutral → (moderate move); technical trend raise-2026-07-20; trading at ₹559.85 (+0.34% today); neutral (RSI 59).

Data as of Aug 14 2026, 6:50 PM. Informational analytics only — not investment advice.

Key metrics

What's driving the signal

• -Near 52w High; +Strong Up
• RSI is neutral
• Relative volume 15.27× (elevated)
• 1% below its 52-week high
• 62% above its 52-week low

Frequently asked about THYROCARE

What is AkshayaAI's signal for THYROCARE today?

As of Aug 14 2026, 6:50 PM, AkshayaAI's signal for THYROCARE (Thyrocare Technologies Limited) is Neutral with a moderate move, and its technical trend is raise-2026-07-20. The composite score and full factor breakdown are available to signed-in members.

Is THYROCARE overbought or oversold right now?

THYROCARE's RSI is neutral (RSI 59). A reading above 70 is typically overbought and below 30 oversold.

Where is THYROCARE in its 52-week range?

THYROCARE is trading about 1% below its 52-week high and 62% above its 52-week low as of Aug 14 2026, 6:50 PM.

What is THYROCARE's market capitalisation?

THYROCARE's market capitalisation is ₹9,932 Cr as of Aug 14 2026, 6:50 PM.

What sector is THYROCARE in?

THYROCARE is classified under Diagnostics & Research in AkshayaAI's taxonomy.

AkshayaAI provides AI-generated, informational stock analytics for US and India markets. This is not personalized investment advice. Figures are as of Aug 14 2026, 6:50 PM and may not reflect real-time prices. Always do your own research. How these signals work →